UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia

BJOG : an international journal of obstetrics and gynaecology, 2022-01, Vol.129 (1), p.63-71

2022

Volltextzugriff (PDF)

033 Teenage sex, what about it?

European journal of obstetrics & gynecology and reproductive biology, 2022-06, Vol.273, p.e13

Apter, D.

2022

Volltextzugriff (PDF)

049 Menstrual cycle and endocrine changes during puberty

European journal of obstetrics & gynecology and reproductive biology, 2022-06, Vol.273, p.e19

Apter, D.

2022

Volltextzugriff (PDF)

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18

International journal of cancer, 2012-07, Vol.131 (1), p.106-116

2012

Volltextzugriff (PDF)

I16 Guidelines, counseling and sexuality education for improving contraceptive use

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S5-S5

Apter, D.

2009

Volltextzugriff (PDF)

I15 The impact of sexuality education programmes on future sexual and reproductive health

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S4-S4

Apter, D.

2009

Volltextzugriff (PDF)

Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol

Human reproduction (Oxford), 2001-03, Vol.16 (3), p.469-475

2001

Volltextzugriff (PDF)

Phase III study of a new, low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS19.5mg) over 5 years of use: evaluation of bleeding and dysmenorrhea

Fertility and sterility, 2015-09, Vol.104 (3), p.e232-e232

2015

Volltextzugriff (PDF)

Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring

Obstetrics and gynecology (New York. 1953), 2002-09, Vol.100 (3), p.585-593

2002

Volltextzugriff (PDF)

A 12-month, Phase III study of a low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS13.5mg) in postmenarcheal adolescents: an evaluation of placement ease and pain, bleeding and dysmenorrhea

FERTILITY AND STERILITY, 2015-09, Vol.104 (3), p.e39-e39

2015

Volltextzugriff (PDF)

Efficacy and safety of a low-dose levonorgestrel intrauterine system (LNG-IUS12) according to age, parity, and body mass index over 5 years of use

FERTILITY AND STERILITY, 2016-09, Vol.106 (3), p.e7-e8

2016

Volltextzugriff (PDF)

ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives

The European journal of contraception & reproductive health care, 2017-08, Vol.22 (4), p.247-249

2017

Volltextzugriff (PDF)

A phase III single-arm study of a new 13.5 mg levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents: an evaluation of efficacy, bleeding, user satisfaction, and placement

FERTILITY AND STERILITY, 2014-09, Vol.102 (3), p.e141-e142

2014

Volltextzugriff (PDF)

A multicenter, open-label, single-arm study exploring the safety of a new 13.5 mg total dose levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents

FERTILITY AND STERILITY, 2014-09, Vol.102 (3), p.e12-e13

2014

Volltextzugriff (PDF)

Return to fertility after removal of two low-dose levonorgestrel intrauterine systems (LNG-IUS): results from a global, randomized, phase III study

Fertility and sterility, 2013-09, Vol.100 (3), p.S57-S58

2013

Volltextzugriff (PDF)

Vaccination protects against invasive HPV‐associated cancers

International journal of cancer, 2018-05, Vol.142 (10), p.2186-2187

2018

Volltextzugriff (PDF)

A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena

Fertility and sterility, 2012-03, Vol.97 (3), p.616-622.e3

2012

Volltextzugriff (PDF)

Bleeding profiles of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSs) used for contraception in nulliparous and parous women: results of a global, randomized, phasE III study

Fertility and sterility, 2012-09, Vol.98 (3), p.S194-S194

2012

Volltextzugriff (PDF)

A global, randomized, phase III, pearl index study comparing the efficacy and safety of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSS) in nulliparous and parous women

Fertility and sterility, 2012-09, Vol.98 (3), p.S5-S5

2012

Volltextzugriff (PDF)

Pharmacokinetics (PK) and effect on ovarian and cervical function of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSS): results of randomized, phase II and III studies

Fertility and sterility, 2012-09, Vol.98 (3), p.S5-S5

2012

Volltextzugriff (PDF)

Endometrial bleeding

Human Reproduction Update, 2007-09, Vol.13 (5), p.421-431

2007

Volltextzugriff (PDF)

Development of the Hypothalamic-Pituitary-Ovarian Axis

Annals of the New York Academy of Sciences, 1997-01, Vol.816 (1), p.9-21

APTER, DAN

1997

Volltextzugriff (PDF)

I020 SUBGROUP ANALYSES OF A RANDOMIZED, PHASE II STUDY COMPARING TWO LOW DOSE LEVONORGESTREL IUSs WITH MIRENA

International journal of gynecology and obstetrics, 2012-10, Vol.119 (S3), p.S166-S166

2012

Volltextzugriff (PDF)

Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies

Fertility and sterility, 2014-06, Vol.101 (6), p.1656-1662.e4

2014

Volltextzugriff (PDF)

1 – 25 von 650

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(589)
Mit Volltextzugriff
(512)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(327)
Life Sciences & Biomedicine
(317)
Humans
(312)
Female
(254)
Adolescent
(181)
Biological And Medical Sciences
(164)
Male
(161)
Adult
(152)
Medical Sciences
(149)
Psychiatry
(106)
Medicin Och Hälsovetenskap
(101)
Social Sciences
(80)
Psychology
(70)
Child
(66)
Immunology
(57)
Middle Aged
(55)
Psychology. Psychoanalysis. Psychiatry
(55)
Risk Factors
(49)
Teenagers
(48)
Allergy And Immunology
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia

033 Teenage sex, what about it?

049 Menstrual cycle and endocrine changes during puberty

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18

I16 Guidelines, counseling and sexuality education for improving contraceptive use

I15 The impact of sexuality education programmes on future sexual and reproductive health

Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol

Phase III study of a new, low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS19.5mg) over 5 years of use: evaluation of bleeding and dysmenorrhea

Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring

A 12-month, Phase III study of a low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS13.5mg) in postmenarcheal adolescents: an evaluation of placement ease and pain, bleeding and dysmenorrhea

Efficacy and safety of a low-dose levonorgestrel intrauterine system (LNG-IUS12) according to age, parity, and body mass index over 5 years of use

ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives

A phase III single-arm study of a new 13.5 mg levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents: an evaluation of efficacy, bleeding, user satisfaction, and placement

A multicenter, open-label, single-arm study exploring the safety of a new 13.5 mg total dose levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents

Return to fertility after removal of two low-dose levonorgestrel intrauterine systems (LNG-IUS): results from a global, randomized, phase III study

Vaccination protects against invasive HPV‐associated cancers

A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena

Bleeding profiles of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSs) used for contraception in nulliparous and parous women: results of a global, randomized, phasE III study

A global, randomized, phase III, pearl index study comparing the efficacy and safety of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSS) in nulliparous and parous women

Pharmacokinetics (PK) and effect on ovarian and cervical function of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSS): results of randomized, phase II and III studies

Endometrial bleeding

Development of the Hypothalamic-Pituitary-Ovarian Axis

I020 SUBGROUP ANALYSES OF A RANDOMIZED, PHASE II STUDY COMPARING TWO LOW DOSE LEVONORGESTREL IUSs WITH MIRENA

Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies

Suchergebnisse filtern